Ákos Csonka

512 total citations
33 papers, 405 citations indexed

About

Ákos Csonka is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Ákos Csonka has authored 33 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Surgery. Recurrent topics in Ákos Csonka's work include Drug Transport and Resistance Mechanisms (9 papers), Phenothiazines and Benzothiazines Synthesis and Activities (6 papers) and Cancer therapeutics and mechanisms (5 papers). Ákos Csonka is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Phenothiazines and Benzothiazines Synthesis and Activities (6 papers) and Cancer therapeutics and mechanisms (5 papers). Ákos Csonka collaborates with scholars based in Hungary, Pakistan and Portugal. Ákos Csonka's co-authors include Joséph Molnár, Gabriella Spengler, Leonard Amaral, Diána Szabó, Abdur Rauf, Bina S. Siddiqui, Ghias Uddin, Endre Varga, Zsuzsanna Valkusz and Anikó Pósa and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Pharmacology and Phytotherapy Research.

In The Last Decade

Ákos Csonka

30 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ákos Csonka Hungary 11 228 110 65 33 27 33 405
Belal O. Al‐Najjar Jordan 11 138 0.6× 138 1.3× 41 0.6× 35 1.1× 17 0.6× 44 373
Fengli Xu China 12 218 1.0× 69 0.6× 32 0.5× 45 1.4× 25 0.9× 14 464
Xu Wei China 9 193 0.8× 147 1.3× 43 0.7× 102 3.1× 38 1.4× 20 493
Aamir Nazir India 13 231 1.0× 63 0.6× 22 0.3× 43 1.3× 23 0.9× 49 598
Yali Zhang China 11 243 1.1× 70 0.6× 19 0.3× 38 1.2× 18 0.7× 22 493
Gaozhong Cao China 6 134 0.6× 77 0.7× 17 0.3× 26 0.8× 27 1.0× 7 380
Haifeng Cui China 10 211 0.9× 87 0.8× 33 0.5× 78 2.4× 11 0.4× 26 393
Md Arshad India 11 106 0.5× 75 0.7× 22 0.3× 42 1.3× 16 0.6× 21 366
Mahendar Porika India 11 199 0.9× 93 0.8× 37 0.6× 16 0.5× 15 0.6× 23 433

Countries citing papers authored by Ákos Csonka

Since Specialization
Citations

This map shows the geographic impact of Ákos Csonka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ákos Csonka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ákos Csonka more than expected).

Fields of papers citing papers by Ákos Csonka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ákos Csonka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ákos Csonka. The network helps show where Ákos Csonka may publish in the future.

Co-authorship network of co-authors of Ákos Csonka

This figure shows the co-authorship network connecting the top 25 collaborators of Ákos Csonka. A scholar is included among the top collaborators of Ákos Csonka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ákos Csonka. Ákos Csonka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Várkonyi, Á., Ákos Csonka, András Szász, et al.. (2025). Endothelial–Mesenchymal Transition and Possible Role of Cytokines in Streptozotocin-Induced Diabetic Heart. Biomedicines. 13(5). 1148–1148. 1 indexed citations
2.
Kupai, Krisztina, et al.. (2024). Bone Loss in Diabetes Mellitus: Diaporosis. International Journal of Molecular Sciences. 25(13). 7269–7269. 5 indexed citations
3.
Kincses, Annamária, et al.. (2024). Selenocompounds as Potent Efflux Pump Inhibitors on Gram‐positive Bacteria. ChemMedChem. 20(2). e202400691–e202400691. 1 indexed citations
4.
Rárosi, Ferenc, et al.. (2022). Bisphosphonate therapy associated with bilateral atypical femoral fracture and delayed union. Joint Diseases and Related Surgery. 33(1). 24–32. 1 indexed citations
5.
Rauf, Abdur, Saud Bawazeer, Muslim Raza, et al.. (2021). Reversal of multidrug resistance and antitumor promoting activity of 3-oxo-6β-hydroxy- β-amyrin isolated from Pistacia integerrima. Biocell. 45(1). 139–147. 9 indexed citations
6.
Gajdács, Márió, Márta Nové, Ákos Csonka, et al.. (2020). Phenothiazines and Selenocompounds: A Potential Novel Combination Therapy of Multidrug Resistant Cancer. Anticancer Research. 40(9). 4921–4928. 7 indexed citations
7.
Ábrahám, Edit, Ákos Csonka, Péter Vilmos, et al.. (2020). Novel perspectives of target-binding by the evolutionarily conserved PP4 phosphatase. Open Biology. 10(12). 200343–200343. 14 indexed citations
8.
Doró, Péter, et al.. (2020). Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy. Journal of Orthopaedic Surgery and Research. 15(1). 414–414. 14 indexed citations
9.
Csonka, Ákos, et al.. (2020). Multidisciplinary treatment of a complicated crural degloving injury in a diabetic patient. Injury. 52. S74–S77. 2 indexed citations
10.
Rauf, Abdur, Muslim Raza, Ghias Uddin, et al.. (2018). Multidrug resistance reversal activity of extract and a rare dimeric naphthoquinone from Diospyros lotus.. PubMed. 31(3). 821–825. 2 indexed citations
11.
Csonka, Ákos, et al.. (2017). Possible Biological and Clinical Applications of Phenothiazines. Anticancer Research. 37(11). 5983–5993. 113 indexed citations
12.
Cyboran-Mikołajczyk, Sylwia, Ákos Csonka, Joséph Molnár, et al.. (2017). In Vitro Studies of Anti-Hemolytic and Cytotoxic Activity of Procyanidin-Rich Extract from the Leaves of Actinidia arguta. Polish Journal of Food and Nutrition Sciences. 68(2). 171–177. 8 indexed citations
13.
Rauf, Abdur, Ghias Uddin, Muslim Raza, et al.. (2016). Reversal of Multidrug Resistance and Computational Studies of Pistagremic Acid Isolated from Pistacia integerrima. Asian Pacific Journal of Cancer Prevention. 17(4). 2311–2314. 5 indexed citations
14.
Spengler, Gabriella, Ákos Csonka, Joséph Molnár, & Leonard Amaral. (2016). The Anticancer Activity of the Old Neuroleptic Phenothiazine-type Drug Thioridazine. Anticancer Research. 36(11). 5701–5706. 49 indexed citations
15.
16.
Rauf, Abdur, Ghias Uddin, Muslim Raza, et al.. (2016). Reversal of Multidrug Resistance in Mouse Lymphoma Cells by Extracts and Flavonoids from Pistacia integerrima. Asian Pacific Journal of Cancer Prevention. 17(1). 51–55. 16 indexed citations
17.
Das, Umashankar, et al.. (2016). 1-[3-(2-Hydroxyethylsulfanyl)propanoyl]-3,5-bis(benzylidene)-4-piperidones: A novel cluster of P-glycoprotein dependent multidrug resistance modulators. Bioorganic & Medicinal Chemistry Letters. 26(4). 1319–1321. 7 indexed citations
18.
Csonka, Ákos, et al.. (2015). External cooling efficiently controls intraosseous temperature rise caused by drilling in a drilling guide system: an in vitro study. British Journal of Oral and Maxillofacial Surgery. 53(10). 963–967. 17 indexed citations
19.
Rauf, Abdur, Ghias Uddin, Bina S. Siddiqui, et al.. (2015). A Rare Class of New Dimeric Naphthoquinones from Diospyros lotus have Multidrug Reversal and Antiproliferative Effects. Frontiers in Pharmacology. 6. 293–293. 19 indexed citations
20.
Csonka, Ákos, Sami Hamdoun, Gabriella Spengler, et al.. (2015). Substituted steroidal compounds containing amino and amido groups reverse multidrug resistance of mouse T-lymphoma and two human prostate cancer cell lines in vitro.. PubMed. 35(4). 2105–12. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Belal O. Al‐Najjar Breakdown of academic impact, for papers by Fengli Xu Breakdown of academic impact, for papers by Xu Wei Breakdown of academic impact, for papers by Aamir Nazir Breakdown of academic impact, for papers by Yali Zhang Breakdown of academic impact, for papers by Gaozhong Cao Breakdown of academic impact, for papers by Haifeng Cui Breakdown of academic impact, for papers by Md Arshad Breakdown of academic impact, for papers by Mahendar Porika
Rankless by CCL
2026